bibliographic resource 349810 [br/349810]
https://w3id.org/oc/corpus/br/349810

is a
title
  • Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
publication date
  • 2011-01-01
contributor
format
identifier
part of